IPCA-Zopiclone

País: Nova Zelanda

Idioma: anglès

Font: Medsafe (Medicines Safety Authority)

ingredients actius:

Zopiclone 3.75mg;  

Disponible des:

Ipca Pharma (NZ) Pty Limited

Designació comuna internacional (DCI):

Zopiclone 3.75 mg

Dosis:

3.75 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Zopiclone 3.75mg   Excipient: Calcium hydrogen phosphate dihydrate Colloidal silicon dioxide Hypromellose Indigo carmine aluminium lake Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone Purified talc Sodium starch glycolate Titanium dioxide

tipo de receta:

Class C5 Controlled Drug

Fabricat per:

Centaur Pharmaceuticals Private Limited

indicaciones terapéuticas:

Treatment of transient, short-term and chronic insomnia in adults including difficulties with falling asleep, nocturnal awakening and wakening.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, PVC/Al in outer cardboard carton - 28 tablets - 36 months from date of manufacture stored at or below 25°C protect from light

Data d'autorització:

2013-06-14